Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
Overlapping gastrointestinal symptoms of functional gastrointestinal diseases (FGIDs) is an
internationally recognized problem in modern medical diagnosis and treatment. Such patients
show more physical symptoms and worse quality of life, resulting in a huge economic burden.
At present, FGIDs gastrointestinal symptoms overlap, lack of effective and systematic
treatment, and the treatment goal is to improve symptoms.The study plans to carry out a multi
center and large sample RCT clinical study of Tongjiang granule in the treatment of
overlapping gastrointestinal symptoms of non erosive reflux disease(NERD)and epigastric pain
syndrome（EPS, so as to provide high-level evidence-based evidence for the treatment of
overlapping symptoms of FGIDs and form a diagnosis and treatment scheme that can be
popularized.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Collaborators:
First Affiliated Hospital of Heilongjiang Chinese Medicine University Liuzhou Hospital of Traditional Chinese Medicine Yueyang Hospital of Integrated Traditional Chinese and Western Medicine